Human Microbiome as an Immunoregulatory Axis: Mechanisms, Dysbiosis, and Therapeutic Modulation
Microorganisms · 14.09.2025 · 13 (9) · 2147
DOI: 10.3390/microorganisms13092147 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 14.09.2025. Verfasst von Matías Cortés und 8 weiteren Autor:innen. Beteiligte Einrichtung: Carrera de Biotecnología, Universidad de La Frontera, Temuco 4811230, Chile. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Nacional de Investigación y Desarrollo.
Abstract (Originalsprache)
The human microbiome plays a central role in modulating the immune system and maintaining immunophysiological homeostasis, contributing to the prevention of immune-mediated diseases. In particular, the gut microbiota is a key ecosystem for immune system maturation, especially in early life. This review aimed to analyze the molecular and cellular mechanisms linking the microbiome to immune and neuronal functions, as well as the impact of dysbiosis and emerging therapeutic strategies targeting the microbiome. The analysis was based on scientific databases, prioritizing studies published since 2000, with special emphasis on the past decade. The microbiome influences immune signaling through microorganism-associated molecular patterns (MAMPs) and pattern recognition receptors (PRRs), including Toll-like receptors (TLRs). Additionally, microbial metabolites—such as short-chain fatty acids (SCFAs), tryptophan derivatives, and secondary bile acids—exert significant immunomodulatory effects. The intestinal epithelial barrier is also described as an active immunological interface contributing to systemic regulation. The literature highlights innovative therapies, including fecal microbiota transplantation (FMT), probiotics, and microbiome editing with CRISPR-Cas technologies. These strategies aim to restore microbial balance and improve immune outcomes. The growing body of evidence positions the microbiome as a valuable clinical and diagnostic target, with significant potential for application in personalized medicine.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Carrera de Biotecnología, Universidad de La Frontera, Temuco 4811230, Chile.
- Centro de Tecnología e Innovación de La Carne, Universidad de la Frontera, Temuco 4780000, Chile.
- Biocontrol Research Laboratory, Universidad de La Frontera, Temuco 4811230, Chile.
- Facultad de Ciencias Agropecuarias y Medioambiente, Universidad de La Frontera, Temuco 4780000, Chile.
- Doctoral Program in Science Major in Applied Cellular and Molecular Biology, Universidad de La Frontera, Av. Francisco Salazar 01145, Temuco 4811230, Chile.
- UWA Institute of Agriculture, The University of Western Australia, Perth 6009, Australia.
ORCID-Profile: Matías Cortés, Rodrigo Rodriguez, Rommy Diaz, Nestor Sepulveda, Erwin A Paz, John Quiñones
Förderung
- Agencia Nacional de Investigación y Desarrollo
Zitieren
APA
Cortés, M., Olate, P., Rodriguez, R., Diaz, R., Martínez, A., Hernández, G., Sepulveda, N., Paz, E. A., & Quiñones, J. (2025). Human Microbiome as an Immunoregulatory Axis: Mechanisms, Dysbiosis, and Therapeutic Modulation. Microorganisms, 13(9), 2147. https://doi.org/10.3390/microorganisms13092147
Vancouver
Cortés M, Olate P, Rodriguez R, Diaz R, Martínez A, Hernández G, et al. Human Microbiome as an Immunoregulatory Axis: Mechanisms, Dysbiosis, and Therapeutic Modulation. Microorganisms. 2025;13(9):2147. doi:10.3390/microorganisms13092147
BibTeX
@article{Corts2025,
author = {Cortés, Matías and Olate, Paula and Rodriguez, Rodrigo and Diaz, Rommy and Martínez, Ailín and Hernández, Genisley and Sepulveda, Nestor and Paz, Erwin A and Quiñones, John},
title = {Human Microbiome as an Immunoregulatory Axis: Mechanisms, Dysbiosis, and Therapeutic Modulation},
journal = {Microorganisms},
year = {2025},
volume = {13},
number = {9},
pages = {2147},
doi = {10.3390/microorganisms13092147}
}
EUVIMED